Perkinelmer, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2018
January 01, 2019 at 02:45 am IST
Share
PerkinElmer, Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2018. For the quarter, the company announced revenue of $756,349,000 compared to $641,630,000 a year ago. Operating income from continuing operations was $115,683,000 compared to $93,583,000 a year ago. Net income was $71,292,000 or $0.64 per diluted share compared to loss of $41,117,000 or $0.37 per diluted share a year ago.
For the year, the company announced revenue of $2,777,996,000 compared to $2,256,982,000 a year ago. Operating income from continuing operations was $323,884,000 compared to $295,615,000 a year ago. Net income was $237,927,000 or $2.13 per diluted share compared to $292,633,000 or $2.64 per diluted share a year ago.
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
REVVITY, INC. 
